Key statistics
On Tuesday, Femasys Inc (FEMY:NAQ) closed at 1.13, 53.95% above the 52 week low of 0.734 set on Jan 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.09 |
---|---|
High | 1.14 |
Low | 1.07 |
Bid | 1.09 |
Offer | 1.13 |
Previous close | 1.09 |
Average volume | 79.55k |
---|---|
Shares outstanding | 22.23m |
Free float | 20.54m |
P/E (TTM) | -- |
Market cap | 24.23m USD |
EPS (TTM) | -0.8468 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
- Femasys Announces Infertility Clinic Customers from Coast to Coast
- Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
- Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
- Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting
- Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
- Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
- Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
- Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
More ▼